Insider Trading & Ownership of Kate Haviland

Location: Cambridge, MA
Summary: The estimated net worth of Kate Haviland is at least $2,636,411 dollars as of 01 May 2026. Kate Haviland is the Chief Executive Officer, Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp stock worth about $2.54M. Kate Haviland is the Director of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $98.5K.
Signature: /s/ Douglas Carlson
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow Kate Haviland and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

Kate Haviland has 4 issuer positions tracked on this page.
Estimated disclosed ownership value: $2,636,411.
Recent insider filing activity is available below.

Change

Largest disclosed position: Blueprint Medicines Corp ($2,537,920).
Past-year value change for that position: .

Research use

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.